Patient portal

Branca Bartelet

For her PhD, Branca will focus on reprogramming immune cells using mRNA nanotherapy, enabling them to produce cytokines that attract and activate T cells. Immunotherapy has shown promising results in the treatment of cancer, but faces challenges in high-grade glioma (HGG), a deadly form of brain cancer. These tumours are characterized by an immunosuppressive tumour immune microenvironment (TIME) with immune cells that strongly suppress T cells, which would normally kill cancer cells. Moreover, its location behind the blood-brain barrier complicates effective delivery of immunotherapy to the tumour. Therefore, she will also use ultrasound-guided opening of the blood-brain barrier aimed at enhancing immune cell infiltration in the tumour to achieve more effective tumour cell killing.